Table 1 Univariable logistic regression models were used to assess the influence of different variables (initial CNV size (GLD), initial PED, initial central retinal thickness, initial type of lesion, age of patient, time between first consultation to first injection) on response to ranibizumab therapy

From: Risk factors of a reduced response to ranibizumab treatment for neovascular age-related macular degeneration – evaluation in a clinical setting